Company Analysis

Cumberland Pharmaceuticals Inc. (CPIX)

Nasdaq: CPIX · Pharmaceutical Preparations · Nashville,, TN · filing with the SEC since 2002
Grade6.0
◀ Past 5.5● Present 6.7▶ Future 5.4

Who runs Cumberland Pharmaceuticals Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Kazimi A J
Chairman and CEO. First filing Aug 2009, latest Mar 20, 2026, 22 filings in all.
Officers reporting now
5
of 10 people with a filing in the last fifteen months
Directors reporting now
5
18 people on the record since 2009
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Kazimi A JChairman and CEOAug 2009Mar 20, 2026none
Hamm John M.VP Chief Financial OfficerJul 2021Mar 20, 2026none
Herman James LVP and Chief Compliance OfficeMar 2013Mar 20, 2026none
Anthony Todd M.Vice Pres Organizational DevMar 2023Mar 20, 2026none
Bitterman Chris T.Vice Pres Sales & MarketingMar 2023Mar 20, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Brown Martin S JrdirectorJul 2022Mar 20, 2026none
Galante Joseph CdirectorApr 2018Mar 20, 2026none
Jones JamesdirectorApr 2010Mar 20, 2026none
Krogulski KennethdirectorJan 2017Mar 20, 2026none
Young CarolinedirectorSep 2016Mar 20, 2026none
Earlier names on the record8, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CPIX · research, not advice